Workflow
Biocause Pharma(000627)
icon
Search documents
天茂集团:天茂集团业绩说明会、路演活动信息
2023-05-09 08:24
证券代码:000627 证券简称:天茂集团 天茂实业集团股份有限公司 2022 年度业绩说明会投资者关系活动记录表 编号:2023-投-001 | | □特定对象调研 分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访  业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他(请文字说明其他活动内容) | | 参与单位名称及 | 天茂集团 2022 年度业绩说明会通过全景网"投资者关系互动平台" | | 人员姓名 | | | | (https://ir.p5w.net)以线上方式举行,面向全体投资者 | | | 2023 年 5 月 8 日下午(星期一)15:00-17:00 | | 时间 | | | 地点 | 全景网"投资者关系互动平台"(https://ir.p5w.net) | | | 公司董事长刘益谦先生、总经理周文霞女士、财务总监陈大力先生、独立 | | 上市公司接待人 | | | 员姓名 | 董事姜海华先生、董事会秘书龙飞先生以及国华人寿保险股份有限公司副 | | | 总经理、财务负责人冀爱萍女士。 | | | 投资者关注 ...
天茂集团(000627) - 2023 Q1 - 季度财报
2023-04-27 16:00
天茂实业集团股份有限公司董事会 2023 年 04 月 27 日 证券代码:000627 证券简称:天茂集团 公告编号:2023-018 重要内容提示: 3.第一季度报告是否经审计 天茂实业集团股份有限公司 2023 年第一季度报告 | --- | --- | --- | --- | |-----------------------------------------------|--------------------|--------------------|----------------------------------| | □是 否 | 本报告期 | 上年同期 | 本报告期比上年同期增减 ( % ) | | 营业收入(元) | 21,927,557,710.48 | 18,214,993,909.49 | 20.38% | | 归属于上市公司股东的净利 润(元) | 45,205,131.10 | 147,295,418.16 | -69.31% | | 归属于上市公司股东的扣除 非经常性损益的净利润 | 43,721,831.79 | 150,111,380.68 | -70.87% | | ...
天茂集团(000627) - 2022 Q4 - 年度财报
2023-04-21 16:00
Financial Performance - The company's operating revenue for 2022 was ¥49,615,695,080.12, representing a slight increase of 0.07% compared to ¥49,583,190,777.91 in 2021[36]. - Net profit attributable to shareholders for 2022 was ¥274,051,117.04, a decrease of 41.78% from ¥470,713,660.35 in 2021[36]. - The net profit after deducting non-recurring gains and losses was ¥255,943,705.42, down 42.95% from ¥448,641,556.40 in the previous year[36]. - Basic and diluted earnings per share both decreased by 40.00% to ¥0.06 from ¥0.10 in 2021[36]. - The company's operating costs for 2022 amounted to 49,370.10 million, representing a 0.34% increase compared to 2021[150]. - The net profit attributable to the parent company was 274,051,117.04, down by 196,662,543.31 or 41.78% year-over-year, influenced by business structure optimization and capital market volatility[160]. Cash Flow - The cash flow from operating activities increased by 80.32% to ¥7,524,197,273.04, compared to ¥4,172,608,401.49 in 2021[36]. - The net cash flow from operating activities was 7,524,197,273.04, an increase of 80.32% compared to the previous year, reflecting improved cash receipts from reinsurance business[170]. - The cash flow from operating activities decreased by 4.14% in 2022, while cash flow from financing activities increased by 54.28%[156]. - The total cash inflow from financing activities was 12,459,035,000.00, a rise of 54.28% year-over-year, indicating increased capital raising efforts[170]. - The total cash outflow from financing activities was 1,381,212,616.54, which increased by 203.48% compared to the previous year, reflecting higher financing costs[170]. Assets and Liabilities - The total assets at the end of 2022 were ¥288,598,690,187.29, an increase of 9.36% from ¥263,903,965,776.01 at the end of 2021[36]. - The net assets attributable to shareholders decreased by 5.06% to ¥21,411,955,513.57 from ¥22,553,333,829.41 in 2021[36]. - The company's total assets reached 281.267 billion RMB by December 31, 2022, an increase of 13.114 billion RMB (4.9%) compared to the end of 2021[90]. - The company's investment assets increased by 9.74% to 250.129 billion RMB by December 31, 2022, driven by increased operating income and net premium inflow[91]. - The asset-liability ratio increased to 90.47% in 2022 from 88.21% in 2021[136]. Insurance Business - Insurance business revenue for 2022 was RMB 37,819.75 million, a decrease of 0.83% from RMB 38,136.19 million in 2021[53]. - Earned premium increased by 1.03% to RMB 37,767.59 million, compared to RMB 37,383.85 million in the previous year[53]. - Net profit dropped significantly by 42.96% to RMB 484.16 million from RMB 848.77 million in 2021[53]. - The company achieved a renewal premium of nearly RMB 16 billion, accounting for over 40% of total premiums[54]. - The company maintained a 13-month continuation rate of 93.47%, an increase of 1.03% from 92.44% in 2021[53]. - In 2022, the insurance business revenue accounted for 99.99% of the company's main business income, highlighting its core business focus[75]. - The company's life insurance premium income was 36.548 billion RMB in 2022, a decrease of 0.99% from 2021[80]. - The health insurance premium income was 896.13 million RMB, down 2.68% year-on-year[80]. Investment Performance - The investment income decreased by 5.62% to RMB 10,703.97 million, down from RMB 11,341.05 million in 2021[53]. - The company reported a total investment income of 10.704 billion yuan, a decrease of 5.62% year-on-year, with an annualized net investment return rate of 4.04%, down 0.67 percentage points from the previous year[95][118]. - The fair value change loss was -431,840,347.67, a significant decline of 412,813,243.21 or 2169.61% year-over-year, attributed to changes in investment properties and trading financial assets[160]. - Exchange gains amounted to 72,016,331.54, an increase of 87,217,271.97 or 573.76% compared to the previous year, driven by foreign currency fund exchange rate fluctuations[160]. Risk Management - The company has outlined potential risks and countermeasures in its future development outlook section of the management discussion[23]. - The company implemented a "3+4+3" risk control system, covering over 20 provinces and cities, enhancing its risk management capabilities[74]. Governance and Strategy - The company plans to enhance its governance structure and management stability, having introduced state-owned shareholders to optimize its governance[47]. - The company is focusing on value business growth and transitioning towards a mature insurance enterprise[70]. - The company is actively expanding its health and elderly care industry, with projects underway in Shanghai and other major cities[55]. - The company emphasizes optimizing customer service and enhancing service capabilities, achieving breakthroughs in various areas in 2022[50].
天茂集团:天茂集团关于举行2022年度业绩说明会并征集投资者问题的公告0421
2023-04-21 09:14
证券代码:000627 证券简称:天茂集团 公告编号:2023-013 天茂实业集团股份有限公司 关于召开 2022 年度业绩说明会并征集投资者问题的公告 为充分尊重投资者、提升交流的针对性,现就公司 2022 年度业绩说明会提前向投资者公 开征集问题,广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 5 日(星期五)17:00 前访问 https://ir.p5w.net/zj/,或扫描下方二维码,进入问题征集专题页面,或将所关注 问题发送至公司投资者关系邮箱:tmjt@tianmaogroup.net。公司将在 2022 年度业绩说明会 上,对投资者普遍关注的问题进行回答。 欢迎广大投资者积极参与本次网上说明会。 特此公告。 天茂实业集团股份有限公司董事会 2023 年 4 月 21 日 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误 导性陈述或者重大遗漏。 天茂实业集团股份有限公司定于 2023 年 5 月 8 日(星期一)下午 15:00-17:00 在全景 网举办 2022 年度业绩说明会,本次年度业绩说明会将采用网络远程的方式举行,投资者可 登陆全景网"投资者关 ...
天茂集团(000627) - 2016年3月16日投资者关系活动记录表
2022-12-06 11:31
证券代码:000627 证券简称:天茂集团 天茂实业集团股份有限公司投资者关系活动记录表 编号:【2016】第 002 号 | --- | --- | --- | |--------------|------------------------------|----------------------------------------------------------| | | | | | 投资者关系活 | √ 特定对象调研 | □分析师会议 | | 动类别 | □媒体采访 | □业绩说明会 | | | □ 新闻发布会 | □路演活动 | | | □现场参观 | | | | □ 其他 | (请文字说明其他活动内容) | | 参与单位名称 | 东北证券非银行金融行业分析师 | 张经纬 | | 及人员姓名 | | | | 时间 | 2016 年 3 月 16 | 日 | | 地点 | 公司会议室 | | | 上市公司接待 | 董事会秘书 龙飞 | | | 人员姓名 | | | | 投资者关系活 | 调研期间谈论的主要内容: | | | 动主要内容介 | 1 | 、国华人寿在互联网保险这块发展情况 | | | ...
天茂集团(000627) - 2016年1月14日投资者关系活动记录表
2022-12-06 11:18
证券代码:000627 证券简称:天茂集团 天茂实业集团股份有限公司投资者关系活动记录表 编号:【2016】第 001 号 | --- | --- | --- | |--------------|--------------------------|---------------------------------------------------| | | | | | 投资者关系活 | √ 特定对象调研 | □分析师会议 | | 动类别 | □媒体采访 | □业绩说明会 | | | □ 新闻发布会 | □路演活动 | | | □现场参观 | | | | □ 其他 | (请文字说明其他活动内容) | | 参与单位名称 | 华泰证券非银行金融研究员 | 左欣然 | | 及人员姓名 | 长江证券金融高级分析师 | 周晶晶 | | 时间 | 2016 年 1 月 14 | 日 | | 地点 | 公司会议室 | | | 上市公司接待 | 董事会秘书 龙飞 | | | 人员姓名 | | | | 投资者关系活 | 调研期间谈论的主要内容: | | | 动主要内容介 | 1 | 、简单介绍下国华人寿保险股份有限公司的竞争 ...
天茂集团(000627) - 2017年6月28日投资者关系活动记录表
2022-12-06 07:24
证券代码:000627 证券简称:天茂集团 天茂实业集团股份有限公司投资者关系活动记录表 编号:【2017】第 001 号 | --- | --- | --- | |-----------------------|--------------------------------------|-----------------------------------------------------------------------| | | | | | 投资者关系活 | √ 特定对象调研 | □分析师会议 | | 动类别 | □媒体采访 | □业绩说明会 | | | □ 新闻发布会 | □路演活动 | | | □现场参观 | | | | □ 其他 | (请文字说明其他活动内容) | | 参与单位名称 | | 太平洋证券研究院非银金融行业分析师 崔刚 | | 及人员姓名 | | | | 时间 地点 | 2017 年 6 月 28 公司会议室 | 日 | | 上市公司接待 | 董事会秘书: | 龙飞 | | | 证券事务代表:李梦莲 | | | 人员姓名 投资者关系活 | 调研期间谈论的主要内容: | | | 动 ...
天茂集团(000627) - 2018年1月8日投资者关系活动记录表
2022-12-04 10:20
Group 1: Company Overview - Guohua Life aims to be a moderately scaled, well-structured, high-quality, modern management life insurance company that continuously creates value for customers, employees, and shareholders [3]. Group 2: Internal Control - Guohua Life has established a comprehensive internal control system in accordance with relevant requirements, receiving an A-class rating from the insurance regulatory authority [3]. Group 3: Premium Channel Structure - The company will strengthen its competitive advantage in the bank insurance channel by optimizing product structure, reducing liability costs, extending liability duration, and increasing the proportion of risk protection and regular premium businesses [3]. - Guohua Life will vigorously develop internet business, focusing on long-term savings and risk protection products, enhancing cooperation with major internet companies (BATJ), and building its own Huari Internet Insurance platform [3]. - The company plans to gradually increase investment in individual insurance, making it a new growth point and support for business optimization and upgrading [3].
天茂集团(000627) - 2022 Q3 - 季度财报
2022-10-28 16:00
Financial Performance - The company's operating revenue for Q3 2022 was ¥10,229,362,693.07, a decrease of 18.59% compared to the same period last year[7]. - Net profit attributable to shareholders for Q3 2022 was ¥61,471,726.90, an increase of 63.09% year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥46,234,949.96, up 16.31% from the previous year[7]. - Total operating revenue for the period reached ¥37,829,601,508.98, an increase of 6.56% compared to ¥35,488,151,296.07 in the previous period[34]. - Net profit for the period was ¥440,979,794.71, down from ¥649,378,911.12, representing a decrease of 32.0%[37]. - Total comprehensive income attributable to the parent company was -1,303,263,638.74 CNY, compared to 1,298,371,123.38 CNY in the previous period[40]. - The company’s total comprehensive income for the period was -2,581,417,542.17 CNY, compared to 2,504,005,118.40 CNY in the previous period[40]. Assets and Liabilities - The total assets at the end of Q3 2022 reached ¥279,448,652,281.71, reflecting a growth of 5.89% compared to the end of the previous year[7]. - The total liabilities reached ¥244,581,803,254.13, compared to ¥226,429,287,091.68, indicating an increase of 8.0%[33]. - Non-current liabilities totaled ¥221,091,755,795.39, up from ¥213,369,433,187.27, reflecting a growth of 3.4%[33]. - The total equity attributable to shareholders of the parent company decreased to ¥21,224,495,470.78 from ¥22,553,333,829.41, a decline of 5.87%[33]. - The total current assets as of September 30, 2022, amount to 51,320,658,193.01 yuan, compared to 50,358,426,062.72 yuan at the beginning of the year[26]. - The total non-current assets as of September 30, 2022, are 228,127,994,088.70 yuan, compared to 213,545,539,713.29 yuan at the beginning of the year[26]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥852,267,321.02, a 61.32% improvement compared to the same period last year[7]. - Cash flow from financing activities showed a net inflow of 10,855,207,694.08 CNY, compared to 7,763,992,441.06 CNY in the previous period[44]. - Total cash inflow from investment activities was 67,870,371,281.49 CNY, slightly down from 68,315,447,906.06 CNY year-over-year[44]. - Total cash outflow from operating activities was 30,965,869,508.64 CNY, compared to 32,223,724,585.57 CNY in the previous period[44]. - Cash and cash equivalents at the end of the period increased to 24,523,905,725.74 CNY from 21,930,290,560.91 CNY in the previous period[44]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 83,547, with the top ten shareholders holding a significant portion of shares[17]. - New Liyi Group Co., Ltd. holds 44.56% of shares, amounting to 2,201,658,177 shares, with 452,140,000 shares pledged[17]. - Wang Wei, a natural person, holds 11.25% of shares, totaling 555,604,700 shares, with 102,000,000 shares pledged[17]. - Liu Yiqian holds 10.47% of shares, which is 517,500,000 shares, with 116,000,000 shares pledged[17]. - The company has no known related party relationships among the top ten shareholders, ensuring transparency in ownership[23]. Revenue and Income Sources - Insurance business income amounted to ¥28,622,530,924.18, up from ¥27,218,282,678.37, reflecting a growth of 5.16%[34]. - Investment income increased to ¥8,363,650,619.49, compared to ¥7,838,949,131.82, marking a rise of 6.67%[34]. - Cash received from original insurance contracts was 28,266,064,143.83 CNY, up from 26,938,555,900.35 CNY in the previous period[41]. - The company reported a significant increase in policyholder dividends paid, amounting to ¥194,865,811.28, compared to ¥17,806,703.73 in the previous period[37].
天茂集团(000627) - 2022 Q2 - 季度财报
2022-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was ¥27,600,238,815.91, representing a 20.40% increase compared to ¥22,922,959,442.98 in the same period last year[26]. - The net profit attributable to shareholders was ¥176,142,126.86, a decrease of 44.05% from ¥314,813,978.54 in the previous year[26]. - The net profit after deducting non-recurring gains and losses was ¥178,436,783.85, down 38.31% from ¥289,268,184.58 year-on-year[26]. - The net cash flow from operating activities was -¥4,994,823,556.38, an improvement of 30.78% compared to -¥7,215,820,935.99 in the same period last year[26]. - The basic earnings per share were ¥0.036, down 43.75% from ¥0.064 in the same period last year[26]. - The diluted earnings per share were also ¥0.036, reflecting the same percentage decrease of 43.75% compared to the previous year[26]. - The weighted average return on net assets was 0.79%, a decline of 0.69% from 1.48% in the previous year[26]. - The company plans not to distribute cash dividends or issue bonus shares for this reporting period[6]. Premium Income and Insurance Performance - The company's total premium income for the first half of 2022 reached RMB 23.871 billion, a year-on-year increase of 15.76%[41]. - New single premium income amounted to RMB 16.505 billion, while renewal premium income was RMB 7.366 billion[41]. - The company's original premium income grew by 21.52% year-on-year, totaling RMB 21.385 billion[42]. - The life insurance segment saw a 22.21% increase in premium income, reaching RMB 20.921 billion[45]. - Net profit for the first half of 2022 was RMB 310.47 million, a decrease of 46.09% compared to the same period in 2021[36]. - The company maintained a 94.19% 13-month persistency rate, slightly up from 94.17% in the previous year[36]. Assets and Liabilities - The total assets at the end of the reporting period were ¥272,419,735,448.93, an increase of 3.23% from ¥263,903,965,776.01 at the end of the previous year[26]. - The net assets attributable to shareholders decreased by 2.81%, amounting to ¥21,920,490,882.40 compared to ¥22,553,333,829.41 at the end of the previous year[26]. - The company's total assets reached RMB 265,773 million as of June 30, 2022, with total investment assets accounting for 87.74% of total assets[57]. - The investment assets increased by 2.31% to RMB 233,192.75 million compared to RMB 227,922.12 million at the end of 2021[58]. - The company's cash and cash equivalents increased by 9.50% to RMB 24,952.61 million as of June 30, 2022[61]. - The asset-liability ratio increased to 89.05% from 88.21%, suggesting a slight increase in leverage[72]. Investment Performance - The investment return rate for the first half of 2022 was 4.54%, down from 4.83% in the same period last year[36]. - Total investment income for the reporting period was RMB 5,628.16 million, an increase of 1.47% year-on-year, with an annualized net investment return rate of 4.54%, slightly down from the previous year[65]. - The company reported a decrease of 5.77% in the capital guarantee deposits income, which amounted to RMB 20.92 million in the first half of 2022[62]. - The long-term health insurance reserve increased by 22.55% to RMB 1,800.73 million, driven by an increase in renewal premiums[54]. Risk Management - The company faces multiple risks including insurance risk, market risk, credit risk, operational risk, strategic risk, reputation risk, and liquidity risk, all of which are currently manageable[104][106][108][112][114][116][122]. - The company has established a comprehensive risk management system to address insurance risks, including strict monitoring during product development and regular sensitivity analysis[105]. - The market risk management mechanism includes continuous monitoring of market factors and the use of Value at Risk (VaR) and stress testing to mitigate potential losses[107]. - The liquidity coverage ratio meets regulatory thresholds, with sufficient cash and liquid assets to cover obligations as of Q2 2022[119]. Corporate Governance and Shareholding - The company held its annual general meeting on May 23, 2022, with a 66.96% investor participation rate[126]. - There were changes in the board of directors, with the resignation of an independent director and the election of a new independent director on May 23, 2022[127]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period[191]. - The largest shareholder, New Liyi Group, holds 2,201,658,177 shares, representing 44.56% of total shares[183]. - The top ten shareholders collectively hold a significant portion of the company's shares, ensuring stable control[187]. Social Responsibility - The company has actively engaged in social responsibility initiatives, including a donation of 1.42 million yuan to support elderly care in 2,000 communities in Shanghai[135]. - The company contributed nearly 70,000 yuan to enhance sports facilities at a primary school in Chongqing, supporting rural revitalization efforts[135]. - The company has made a total expenditure of 129,262 yuan through a consumption assistance program aimed at helping targeted poverty alleviation areas[135]. Miscellaneous - The company reported no significant environmental penalties or issues during the reporting period[134]. - The company has not engaged in any major litigation or arbitration matters during the reporting period[145]. - The company’s half-year financial report has not been audited[143].